Chlamydia trachomatis infection among Hispanic women in the California-Mexico border area, 1993: establishing screening criteria in a primary care setting

Article Abstract:

Screening all Hispanic women on either side of the California-Mexico border who meet certain criteria which identify them as being at risk for infection with Chlamydia trachomatis may increase detection and treatment. C. trachomatis is the most prevalent sexually transmitted disease (STD) caused by bacteria in the U.S. Researchers tested 2791 low- and middle-income Hispanic women attending any of five clinics providing family planning services or prenatal care, and found the rate of C. trachomatis infection to be 3.2%. Infected women were more likely to be under 25, unmarried, have had sex with an STD-infected male, have had multiple or new sex partners in the last three months, abuse drugs, have vaginal discharge, or exhibit symptoms of chlamydia. Using Centers for Disease Control screening guidelines may result in identifying fewer cases of infection than targeting all of the above-mentioned group of women.

Methods, Chlamydia trachomatis, Hispanic American women, Mexicans

---

The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women

Article Abstract:

Azithromycin may be more cost effective than doxycycline in treating chlamydial infections of the cervix and in preventing the subsequent complications of such infections. Azithromycin is four times more expensive than doxycycline but can be given in one dose, which may increase treatment completion and effectiveness. Researchers used probability models to analyze the cost of the two treatments to healthcare systems and to public health clinics. Azithromycin treatment of chlamydial infection detected by a laboratory may be more effective and less expensive to the healthcare system than doxycycline treatment. Azithromycin treatment may be effective but more expensive for public health clinics as these clinics do not have to cover hospital expenses for treating complications of chlamydial infection such as pelvic inflammatory disease.

Drug therapy, Azithromycin

---

Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: implications for a national Chlamydia control strategy

Article Abstract:

It may be advisable and cost-effective to test all women attending family planning (FP) clinics but only certain populations attending sexually transmitted disease (STD) clinics for chlamydia infections. Rates of chlamydia infections and corresponding risk factors were determined among 19,884 female patients at STD clinics and 11,141 female patients at STD clinics. Overall, 6.6% of these clients had chlamydia. Testing all patients at FP clinics was cost-effective if the prevalence was greater than 3.1% but 7% at STD clinics. Risk factors among affected STD clinic patients included age and high-risk sexual behaviors.

Diagnosis

Similar abstracts:

• Abstracts: Screening for chlamydia trachomatis infection in pregnant women in Martinique. Results of a screening program for Chlamydia trachomatis infection in men attending a sexually transmitted diseases clinic
• Abstracts: Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cells
• Abstracts: Use of folk remedies in a Hispanic population. Home-Based Therapies for the Common Cold Among European American and Ethnic Minority Families
• Abstracts: Legacy of Tuskegee: revelations about the infamous syphilis study turned many African-Americans against the U.S. health care system
• Abstracts: Efficacy of outpatient induction with low-dose intravaginal prostaglandin E2: a randomized, double-blind, placebo-controlled trial

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.